On the other hand, Foxm1 downregulation may contribute to the pathogenesis of del(5q) MDS and AML1-ETO–induced MPN/AML by promoting the CH and influencing genome integrity at the early stage of diseases. This evidence concerns the gene RUNX1T1 and myeloproliferative disorder.